Personalized Medicine Bulletin The source for business, legal, and regulatory developments shaping an evolving industry

Category Archives: AIA

A Cautionary Tale for Patent Applicants

Posted in AIA

When should a patent application be filed? Should it be filed prior to submission of a manuscript or abstract for peer-review or just prior to publication? In highly competitive technologies, it is prudent to file as soon as possible or run the risk of losing potential patent rights to a competitor. While such was good business practice prior to adoption of the first-to-file provisions of the America Invents Act (“AIA”), it is now imperative to file as soon as possible.Continue reading this entry

Status Update on the Genetic Testing Study

Posted in AIA; Diagnostic Methods; Genetic Testing; Personalized Medicine

The U.S. Patent Office recently announced that it will not be delivering its report on Genetic Testing as required under Section 27 of the America Invents Act (“AIA”)  by the June 16, 2012 deadline.Continue reading this entry